Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial
Abstract: Background: Respiratory failure in severe coronavirus disease 2019 (COVID-19) is associated with a severe inflammatory response. Acetylcholine (ACh) reduces systemic inflammation in experimental bacterial and viral infections. Pyridostigmine increases the half-life of endogenous ACh, poten...
Saved in:
Similar Items
-
Pyridostigmine-Induced Microcephaly
by: J Gordon Millichap
Published: (2000) -
Pyridostigmine in the treatment of postural orthostatic tachycardia syndrome
by: İlknur Can, et al.
Published: (2014) -
Pyridostigmine induced heart block requiring ICU admission
by: Benjamin Chaucer, et al.
Published: (2018) -
Comparison of Pyridostigmine and bisacodyl in treatment of refractory chronic constipation.
by: Iman Soufi-Afshar, et al.
Published: (2016) -
High prevalence of late diagnosis of HIV in Mexico during the HAART era
by: Brenda Crabtree-Ramírez, et al.
Published: (2012)